Analystreport

Castle Biosciences, Inc. (NASDAQ: CSTL) had its price target lowered by analysts at SVB Leerink LLC from $85.00 to $75.00. They now have an "outperform" rating on t

Castle Biosciences, Inc. - Common stock  (CSTL) 
Last castle biosciences, inc. - common stock earnings: 3/10 04:05 pm Check Earnings Report